这是一篇来自已证抗体库的有关人类 白细胞介素2 (interleukin 2) 的综述,是根据89篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合白细胞介素2 抗体。
白细胞介素2 同义词: IL-2; TCGF; lymphokine

BioLegend
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 1b
BioLegend白细胞介素2抗体(BioLegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 1b). J Immunol (2019) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 3e
BioLegend白细胞介素2抗体(BioLegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 3e). J Exp Med (2019) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 1b
BioLegend白细胞介素2抗体(BioLegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 1b). J Virol (2019) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 1:100; 图 2e
BioLegend白细胞介素2抗体(Biolegend, 500328)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 2e). Nat Med (2019) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 4c
BioLegend白细胞介素2抗体(BioLegend, 500310)被用于被用于流式细胞仪在人类样本上 (图 4c). J Clin Invest (2018) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 6b
BioLegend白细胞介素2抗体(BioLegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 6b). Sci Rep (2018) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 2j
BioLegend白细胞介素2抗体(BioLegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 2j). J Clin Invest (2018) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 s2b
BioLegend白细胞介素2抗体(Biolegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 s2b). Nature (2017) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 表 s9
BioLegend白细胞介素2抗体(BioLegend, 500331)被用于被用于流式细胞仪在人类样本上 (表 s9). Nature (2017) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 猕猴; 图 3a
BioLegend白细胞介素2抗体(Biolegend, MQ1-17H12)被用于被用于流式细胞仪在猕猴样本上 (图 3a). Proc Natl Acad Sci U S A (2017) ncbi
domestic goat 多克隆(Poly5176)
  • 酶联免疫吸附测定; 小鼠; 图 5a
  • 酶联免疫吸附测定; 人类; 图 4e
BioLegend白细胞介素2抗体(BioLegend, 517605)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 5a) 和 被用于酶联免疫吸附测定在人类样本上 (图 4e). J Immunol (2017) ncbi
大鼠 单克隆(MQ1-17H12)
  • 酶联免疫吸附测定; 人类; 图 4e
  • 酶联免疫吸附测定; 小鼠; 图 5a
BioLegend白细胞介素2抗体(BioLegend, 500302)被用于被用于酶联免疫吸附测定在人类样本上 (图 4e) 和 被用于酶联免疫吸附测定在小鼠样本上 (图 5a). J Immunol (2017) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 猕猴; 表 1
BioLegend白细胞介素2抗体(Biolegend, MQ1-17H12)被用于被用于流式细胞仪在猕猴样本上 (表 1). Vaccine (2017) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
BioLegend白细胞介素2抗体(Biolegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 5a
BioLegend白细胞介素2抗体(Biolegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 5a). Cytokine (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 猕猴
BioLegend白细胞介素2抗体(BioLegend, 500331)被用于被用于流式细胞仪在猕猴样本上. Nat Med (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 3a
BioLegend白细胞介素2抗体(biolegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 3a). J Immunol (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 免疫细胞化学; 人类; 图 6
BioLegend白细胞介素2抗体(BioLegend, MQ1-17H12)被用于被用于免疫细胞化学在人类样本上 (图 6). J Hematol Oncol (2015) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
BioLegend白细胞介素2抗体(Biolegend, clone MQ1-17H12)被用于被用于流式细胞仪在人类样本上. Clin Vaccine Immunol (2015) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 2 ul/test
BioLegend白细胞介素2抗体(Biolegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上浓度为2 ul/test. J Immunol Methods (2015) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
BioLegend白细胞介素2抗体(Biolegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2014) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
BioLegend白细胞介素2抗体(Biolegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. Med Microbiol Immunol (2014) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
BioLegend白细胞介素2抗体(Biolegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 4
BioLegend白细胞介素2抗体(BioLegend, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 4). J Immunol (2014) ncbi
赛默飞世尔
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 s4a
赛默飞世尔白细胞介素2抗体(eBioscience, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 s4a). J Clin Invest (2018) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 s1g
赛默飞世尔白细胞介素2抗体(eBioscience, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 s1g). J Immunol (2018) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 猕猴; 图 s9
赛默飞世尔白细胞介素2抗体(eBiosciences, MQ1-17H21)被用于被用于流式细胞仪在猕猴样本上 (图 s9). PLoS Pathog (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔白细胞介素2抗体(eBioscience, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry A (2017) ncbi
小鼠 单克隆(AB12-3G4)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔白细胞介素2抗体(eBiosciences, AB12-3G4)被用于被用于流式细胞仪在人类样本上 (图 1a). Sci Rep (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 s2
赛默飞世尔白细胞介素2抗体(eBioscience, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 s2). Proc Natl Acad Sci U S A (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔白细胞介素2抗体(eBioscience, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 2). Cancer Immunol Res (2015) ncbi
小鼠 单克隆(419A 7A3)
  • 免疫细胞化学; 人类
  • 酶联免疫吸附测定; 人类
赛默飞世尔白细胞介素2抗体(Life Technologies/Invitrogen Corporation, AHC0422)被用于被用于免疫细胞化学在人类样本上 和 被用于酶联免疫吸附测定在人类样本上. Biochim Biophys Acta (2015) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
赛默飞世尔白细胞介素2抗体(eBioscience, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
赛默飞世尔白细胞介素2抗体(eBioscience, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
赛默飞世尔白细胞介素2抗体(eBioscience, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. J Virol (2015) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
赛默飞世尔白细胞介素2抗体(eBioscience, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔白细胞介素2抗体(eBioscience, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2014) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔白细胞介素2抗体(eBioscience, MQ1-17h12)被用于被用于流式细胞仪在人类样本上 (图 1). Cancer Immunol Immunother (2014) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 s1
赛默飞世尔白细胞介素2抗体(eBioscience, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 s1). PLoS Pathog (2011) ncbi
小鼠 单克隆(297C 16F11)
  • 其他; 人类; 图 4
赛默飞世尔白细胞介素2抗体(Biosource, Invitrogen, AHC0722)被用于被用于其他在人类样本上 (图 4). Anal Biochem (2008) ncbi
小鼠 单克隆(419A 7A3)
  • 酶联免疫吸附测定; 人类; 1 ug/ml; 表 1
赛默飞世尔白细胞介素2抗体(Biosource, 419A7A3)被用于被用于酶联免疫吸附测定在人类样本上浓度为1 ug/ml (表 1). J Leukoc Biol (2004) ncbi
小鼠 单克隆(297C 16G2)
  • 酶联免疫吸附测定; 人类; 0.5 ug/ml; 表 1
赛默飞世尔白细胞介素2抗体(Biosource, 297C1662)被用于被用于酶联免疫吸附测定在人类样本上浓度为0.5 ug/ml (表 1). J Leukoc Biol (2004) ncbi
安迪生物R&D
小鼠 单克隆(5355)
  • 酶联免疫吸附测定; 小鼠; 图 1c, 5f
  • 酶联免疫吸附测定; 人类; 图 7b
安迪生物R&D白细胞介素2抗体(R&D, MAB602)被用于被用于酶联免疫吸附测定在小鼠样本上 (图 1c, 5f) 和 被用于酶联免疫吸附测定在人类样本上 (图 7b). J Immunol (2017) ncbi
小鼠 单克隆(5334)
  • 抑制或激活实验; 人类; 图 5g
安迪生物R&D白细胞介素2抗体(R&D Systems, 5334)被用于被用于抑制或激活实验在人类样本上 (图 5g). Sci Rep (2016) ncbi
小鼠 单克隆(5334)
  • 抑制或激活实验; 人类; 图 3a
安迪生物R&D白细胞介素2抗体(R&D Systems, MAB202)被用于被用于抑制或激活实验在人类样本上 (图 3a). J Biol Chem (2015) ncbi
小鼠 单克隆(5334)
  • 流式细胞仪; 人类
安迪生物R&D白细胞介素2抗体(R&D Systems, 5334)被用于被用于流式细胞仪在人类样本上. J Neuroimmunol (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(LNKB-2)
  • 其他; 人类
圣克鲁斯生物技术白细胞介素2抗体(Santa Cruz, sc-52017)被用于被用于其他在人类样本上. PLoS ONE (2015) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR2780)
  • 免疫组化-石蜡切片; 人类; 1:500; 图 5c
艾博抗(上海)贸易有限公司白细胞介素2抗体(Abcam, ab92381)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 5c). J Immunol Res (2016) ncbi
碧迪BD
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 1:400; 图 s6
碧迪BD白细胞介素2抗体(BD Biosciences, 554567)被用于被用于流式细胞仪在人类样本上浓度为1:400 (图 s6). Science (2019) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 人类; 图 s6b
碧迪BD白细胞介素2抗体(BD, 563946)被用于被用于流式细胞仪在人类样本上 (图 s6b). Cell (2019) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 2d
碧迪BD白细胞介素2抗体(BD Biosciences, 560708)被用于被用于流式细胞仪在人类样本上 (图 2d). Cell Rep (2018) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 2a
碧迪BD白细胞介素2抗体(BD, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 2a). J Immunol (2018) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 5d
碧迪BD白细胞介素2抗体(BD Biosciences, 554567)被用于被用于流式细胞仪在人类样本上 (图 5d). Oncoimmunology (2017) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; African green monkey; 图 s4b
碧迪BD白细胞介素2抗体(BD, MQ1-17H12)被用于被用于流式细胞仪在African green monkey样本上 (图 s4b). Nature (2017) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 人类; 图 5
碧迪BD白细胞介素2抗体(BD, 341116)被用于被用于流式细胞仪在人类样本上 (图 5). Eur J Immunol (2017) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 小鼠; 图 s6d
碧迪BD白细胞介素2抗体(BD Horizon, 5344.111)被用于被用于流式细胞仪在小鼠样本上 (图 s6d). Nature (2017) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 人类; 图 6c
碧迪BD白细胞介素2抗体(BD Bioscience, 5344.111)被用于被用于流式细胞仪在人类样本上 (图 6c). Immunity (2017) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 人类; 图 5a
碧迪BD白细胞介素2抗体(BD Biosciences, 340450)被用于被用于流式细胞仪在人类样本上 (图 5a). Oncoimmunology (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 猕猴; 图 8a
碧迪BD白细胞介素2抗体(BD, 559334)被用于被用于流式细胞仪在猕猴样本上 (图 8a). Sci Rep (2016) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 人类; 图 s2c
碧迪BD白细胞介素2抗体(BD Biosciences, 340448)被用于被用于流式细胞仪在人类样本上 (图 s2c). Cell (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 2e
碧迪BD白细胞介素2抗体(BD Biosciences, 559334)被用于被用于流式细胞仪在人类样本上 (图 2e). J Immunol (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 5
碧迪BD白细胞介素2抗体(BD PharMingen, 560902)被用于被用于流式细胞仪在人类样本上 (图 5). Stem Cell Reports (2016) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 人类; 图 1c
碧迪BD白细胞介素2抗体(BD, 5344.111)被用于被用于流式细胞仪在人类样本上 (图 1c). Clin Immunol (2016) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 人类; 图 2e
碧迪BD白细胞介素2抗体(BD Biosciences, 5344.111)被用于被用于流式细胞仪在人类样本上 (图 2e). J Clin Invest (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 2
碧迪BD白细胞介素2抗体(BD Bioscience, 554567)被用于被用于流式细胞仪在人类样本上 (图 2). Oncoimmunology (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
碧迪BD白细胞介素2抗体(BD, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. J Immunol (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 s1b
碧迪BD白细胞介素2抗体(BD, MQ1-17H2)被用于被用于流式细胞仪在人类样本上 (图 s1b). J Immunol (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 s1
碧迪BD白细胞介素2抗体(BD Pharmingen, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 s1). J Immunol (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 猕猴; 图 st5
碧迪BD白细胞介素2抗体(Beckman Coulter, 554566)被用于被用于流式细胞仪在猕猴样本上 (图 st5). Nat Med (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 1a
碧迪BD白细胞介素2抗体(BD Biosciences, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 表 2
碧迪BD白细胞介素2抗体(BD Biosciences, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (表 2). Vaccine (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 猕猴
碧迪BD白细胞介素2抗体(BD Biosciences, MQ1-17H12)被用于被用于流式细胞仪在猕猴样本上. PLoS ONE (2016) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 猕猴; 图 3d
碧迪BD白细胞介素2抗体(BD Biosciences, 5344.111)被用于被用于流式细胞仪在猕猴样本上 (图 3d). J Immunol (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 s1
碧迪BD白细胞介素2抗体(BD Biosciences, 559334)被用于被用于流式细胞仪在人类样本上 (图 s1). J Clin Invest (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; African green monkey; 图 5a
碧迪BD白细胞介素2抗体(BD Biosciences, MQ1-17H12)被用于被用于流式细胞仪在African green monkey样本上 (图 5a). Infect Immun (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 3b
碧迪BD白细胞介素2抗体(BD Pharmingen, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 3b). PLoS ONE (2016) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 图 s2
碧迪BD白细胞介素2抗体(BD Biosciences, MQ1-17H12)被用于被用于流式细胞仪在人类样本上 (图 s2). PLoS ONE (2015) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 猕猴; 图 3
碧迪BD白细胞介素2抗体(BD Biosciences, MQ1-17H12)被用于被用于流式细胞仪在猕猴样本上 (图 3). J Virol (2016) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 人类; 图 2
  • 流式细胞仪; 犬; 图 2
碧迪BD白细胞介素2抗体(BD, 340450)被用于被用于流式细胞仪在人类样本上 (图 2) 和 被用于流式细胞仪在犬样本上 (图 2). Acta Vet Scand (2015) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
碧迪BD白细胞介素2抗体(BD Biosciences, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 人类; 1:40; 图 1
碧迪BD白细胞介素2抗体(BD, 340448)被用于被用于流式细胞仪在人类样本上浓度为1:40 (图 1). Clin Vaccine Immunol (2015) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类; 4:100; 图 3b
碧迪BD白细胞介素2抗体(Becton Dickinson, MQ1-17H12)被用于被用于流式细胞仪在人类样本上浓度为4:100 (图 3b). Nat Commun (2015) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
碧迪BD白细胞介素2抗体(BD, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2015) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 人类
碧迪BD白细胞介素2抗体(BD Biosciences, 5344.111)被用于被用于流式细胞仪在人类样本上. J Immunol Methods (2015) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 人类
碧迪BD白细胞介素2抗体(BD Bioscience, 5344.11)被用于被用于流式细胞仪在人类样本上. Immun Inflamm Dis (2014) ncbi
小鼠 单克隆(B33-2)
  • 酶联免疫吸附测定; 人类
碧迪BD白细胞介素2抗体(BD Pharmingen, B33-2)被用于被用于酶联免疫吸附测定在人类样本上. J Autoimmun (2015) ncbi
小鼠 单克隆(5344.111)
  • 酶联免疫吸附测定; 人类
碧迪BD白细胞介素2抗体(BD Pharmingen, 5344.111)被用于被用于酶联免疫吸附测定在人类样本上. J Autoimmun (2015) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 人类
碧迪BD白细胞介素2抗体(BD Pharmingen, 5344.111)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
碧迪BD白细胞介素2抗体(BD, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
碧迪BD白细胞介素2抗体(BD Biosciences, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 猕猴
碧迪BD白细胞介素2抗体(BD Biosciences, MQ1-17H12)被用于被用于流式细胞仪在猕猴样本上. J Immunol (2014) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
碧迪BD白细胞介素2抗体(BD, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2014) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
碧迪BD白细胞介素2抗体(BD Biosciences, Clone MQ1-17H12)被用于被用于流式细胞仪在人类样本上. Vaccine (2014) ncbi
小鼠 单克隆(5344.111)
  • 流式细胞仪; 人类
碧迪BD白细胞介素2抗体(BD Biosciences, 5344.111)被用于被用于流式细胞仪在人类样本上. Vaccine (2014) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
碧迪BD白细胞介素2抗体(BD Pharmingen, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. J Virol (2014) ncbi
大鼠 单克隆(MQ1-17H12)
  • 流式细胞仪; 人类
碧迪BD白细胞介素2抗体(BD Biosciences, MQ1-17H12)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
文章列表
  1. Crank M, Ruckwardt T, Chen M, Morabito K, Phung E, Costner P, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science. 2019;365:505-509 pubmed 出版商
  2. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed 出版商
  3. Canete P, Sweet R, Gonzalez Figueroa P, Papa I, Ohkura N, Bolton H, et al. Regulatory roles of IL-10-producing human follicular T cells. J Exp Med. 2019;: pubmed 出版商
  4. Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango M, Kaufmann S, et al. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. Cell. 2019;: pubmed 出版商
  5. Amelio P, Portevin D, Hella J, Reither K, Kamwela L, Lweno O, et al. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses. J Virol. 2019;93: pubmed 出版商
  6. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed 出版商
  7. Wagner D, Amini L, Wendering D, Burkhardt L, Akyüz L, Reinke P, et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat Med. 2019;25:242-248 pubmed 出版商
  8. Kuranda K, Jean Alphonse P, Leborgne C, Hardet R, Collaud F, Marmier S, et al. Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. J Clin Invest. 2018;128:5267-5279 pubmed 出版商
  9. Yang T, St John L, Garber H, Kerros C, Ruisaard K, Clise Dwyer K, et al. Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation. J Immunol. 2018;201:1389-1399 pubmed 出版商
  10. Boutboul D, Kuehn H, Van de Wyngaert Z, Niemela J, Callebaut I, Stoddard J, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest. 2018;128:3071-3087 pubmed 出版商
  11. Zhang C, Peng Y, Hublitz P, Zhang H, Dong T. Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy. Sci Rep. 2018;8:5549 pubmed 出版商
  12. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed 出版商
  13. Wang C, Edilova M, Wagar L, Mujib S, Singer M, Bernard N, et al. Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy. J Immunol. 2018;200:558-564 pubmed 出版商
  14. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed 出版商
  15. Van Caeneghem Y, De Munter S, Tieppo P, Goetgeluk G, Weening K, Verstichel G, et al. Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology. 2017;6:e1283460 pubmed 出版商
  16. Whitfield S, Taylor C, Risdall J, Griffiths G, Jones J, Williamson E, et al. Interference of the T Cell and Antigen-Presenting Cell Costimulatory Pathway Using CTLA4-Ig (Abatacept) Prevents Staphylococcal Enterotoxin B Pathology. J Immunol. 2017;198:3989-3998 pubmed 出版商
  17. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed 出版商
  18. Cardinaud S, Urrutia A, Rouers A, Coulon P, Kervevan J, Richetta C, et al. Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells. Eur J Immunol. 2017;47:818-829 pubmed 出版商
  19. Eyquem J, Mansilla Soto J, Giavridis T, van der Stegen S, Hamieh M, Cunanan K, et al. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature. 2017;543:113-117 pubmed 出版商
  20. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed 出版商
  21. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed 出版商
  22. Mylvaganam G, Rios D, Abdelaal H, Iyer S, Tharp G, Mavigner M, et al. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection. Proc Natl Acad Sci U S A. 2017;114:1976-1981 pubmed 出版商
  23. Parrot T, Oger R, Benlalam H, Raingeard de la Blétière D, Jouand N, Coutolleau A, et al. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells. Oncoimmunology. 2016;5:e1250991 pubmed 出版商
  24. Webb L, Amici S, Jablonski K, Savardekar H, Panfil A, Li L, et al. PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis. J Immunol. 2017;198:1439-1451 pubmed 出版商
  25. Stanfield B, Pahar B, Chouljenko V, Veazey R, Kousoulas K. Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies. Vaccine. 2017;35:536-543 pubmed 出版商
  26. Berry N, Manoussaka M, Ham C, Ferguson D, Tudor H, Mattiuzzo G, et al. Role of Occult and Post-acute Phase Replication in Protective Immunity Induced with a Novel Live Attenuated SIV Vaccine. PLoS Pathog. 2016;12:e1006083 pubmed 出版商
  27. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed 出版商
  28. Kaewkangsadan V, Verma C, Eremin J, Cowley G, Ilyas M, Eremin O. Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer. J Immunol Res. 2016;2016:4757405 pubmed
  29. Swaminathan G, Thoryk E, Cox K, Smith J, Wolf J, Gindy M, et al. A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates. Sci Rep. 2016;6:34215 pubmed 出版商
  30. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed 出版商
  31. Lund P, Elias J, Davis M. Global Analysis of O-GlcNAc Glycoproteins in Activated Human T Cells. J Immunol. 2016;197:3086-3098 pubmed
  32. Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016;7:619-634 pubmed 出版商
  33. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed 出版商
  34. Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. 2016;6:32320 pubmed 出版商
  35. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed 出版商
  36. Peper J, Bösmüller H, Schuster H, Gückel B, Hörzer H, Roehle K, et al. HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy. Oncoimmunology. 2016;5:e1065369 pubmed 出版商
  37. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed 出版商
  38. Suliman S, Geldenhuys H, Johnson J, Hughes J, Smit E, Murphy M, et al. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. J Immunol. 2016;197:1100-1110 pubmed 出版商
  39. Xie L, Zhou F, Liu X, Fang Y, Yu Z, Song N, et al. Serum microRNA181a: Correlates with the intracellular cytokine levels and a potential biomarker for acute graft-versus-host disease. Cytokine. 2016;85:37-44 pubmed 出版商
  40. Coulon P, Richetta C, Rouers A, Blanchet F, Urrutia A, Guerbois M, et al. HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells. J Immunol. 2016;197:517-32 pubmed 出版商
  41. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed 出版商
  42. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed 出版商
  43. Graves S, Kouriba B, Diarra I, Daou M, Niangaly A, Coulibaly D, et al. Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate. Vaccine. 2016;34:2546-55 pubmed 出版商
  44. Zurawski G, Zurawski S, Flamar A, Richert L, Wagner R, Tomaras G, et al. Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques. PLoS ONE. 2016;11:e0153484 pubmed 出版商
  45. Dimitrova M, Zenarruzabeitia O, Borrego F, Simhadri V. CD300c is uniquely expressed on CD56 bright Natural Killer Cells and differs from CD300a upon ligand recognition. Sci Rep. 2016;6:23942 pubmed 出版商
  46. Rueda C, Presicce P, Jackson C, Miller L, Kallapur S, Jobe A, et al. Lipopolysaccharide-Induced Chorioamnionitis Promotes IL-1-Dependent Inflammatory FOXP3+ CD4+ T Cells in the Fetal Rhesus Macaque. J Immunol. 2016;196:3706-15 pubmed 出版商
  47. Macdonald K, Hoeppli R, Huang Q, Gillies J, Luciani D, Orban P, et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J Clin Invest. 2016;126:1413-24 pubmed 出版商
  48. Woo J, Srikanth S, Nishi M, Ping P, Takeshima H, Gwack Y. Junctophilin-4, a component of the endoplasmic reticulum-plasma membrane junctions, regulates Ca2+ dynamics in T cells. Proc Natl Acad Sci U S A. 2016;113:2762-7 pubmed 出版商
  49. Phuah J, Wong E, Gideon H, Maiello P, Coleman M, Hendricks M, et al. Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun. 2016;84:1301-1311 pubmed 出版商
  50. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed 出版商
  51. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed 出版商
  52. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed 出版商
  53. Burbelo P, Klimavicz J, Deeks S, Kovacs J, Ragheb J. Lack of Evidence for Molecular Mimicry in HIV-Infected Subjects. PLoS ONE. 2015;10:e0127662 pubmed 出版商
  54. Bolton D, Pegu A, Wang K, McGinnis K, Nason M, Foulds K, et al. Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs. J Virol. 2016;90:1321-32 pubmed 出版商
  55. Moreira M, Dorneles E, Soares R, Magalhães C, Costa Pereira C, Lage A, et al. Cross-reactivity of commercially available anti-human monoclonal antibodies with canine cytokines: establishment of a reliable panel to detect the functional profile of peripheral blood lymphocytes by intracytoplasmic staining. Acta Vet Scand. 2015;57:51 pubmed 出版商
  56. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed 出版商
  57. Riou C, Tanko R, Soares A, Masson L, Werner L, Garrett N, et al. Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype. J Immunol. 2015;195:2273-2281 pubmed 出版商
  58. Nata T, Basheer A, Cocchi F, van Besien R, Massoud R, Jacobson S, et al. Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum. J Biol Chem. 2015;290:22338-51 pubmed 出版商
  59. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed 出版商
  60. Lenz N, Schindler T, Kagina B, Zhang J, Lukindo T, Mpina M, et al. Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells. Clin Vaccine Immunol. 2015;22:688-96 pubmed 出版商
  61. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed 出版商
  62. Laing K, Russell R, Dong L, Schmid D, Stern M, Magaret A, et al. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus. J Infect Dis. 2015;212:1022-31 pubmed 出版商
  63. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed 出版商
  64. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed 出版商
  65. Kagina B, Mansoor N, Kpamegan E, Penn Nicholson A, Nemes E, Smit E, et al. Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry. J Immunol Methods. 2015;417:22-33 pubmed 出版商
  66. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed 出版商
  67. de Thier P, Bacharouche J, Duval J, Skali Lami S, Francius G. Atomic force microscopy analysis of IgG films at hydrophobic surfaces: a promising method to probe IgG orientations and optimize ELISA tests performance. Biochim Biophys Acta. 2015;1854:138-45 pubmed 出版商
  68. Kong L, Wei J, Haider A, Liebelt B, Ling X, Conrad C, et al. Therapeutic targets in subependymoma. J Neuroimmunol. 2014;277:168-75 pubmed 出版商
  69. Bell C, Sun Y, Nowak U, Clark J, Howlett S, Pekalski M, et al. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells. J Autoimmun. 2015;56:66-80 pubmed 出版商
  70. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed 出版商
  71. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed 出版商
  72. Huss D, Mehta D, Sharma A, You X, Riester K, Sheridan J, et al. In vivo maintenance of human regulatory T cells during CD25 blockade. J Immunol. 2015;194:84-92 pubmed
  73. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed 出版商
  74. Weiskopf D, Angelo M, Bangs D, Sidney J, Paul S, Peters B, et al. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. J Virol. 2015;89:120-8 pubmed 出版商
  75. Mylvaganam G, Velu V, Hong J, Sadagopal S, Kwa S, Basu R, et al. Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa. J Immunol. 2014;193:4527-36 pubmed 出版商
  76. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed 出版商
  77. Kagina B, Tameris M, Geldenhuys H, Hatherill M, Abel B, Hussey G, et al. The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses. Vaccine. 2014;32:5908-17 pubmed 出版商
  78. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed 出版商
  79. Bending D, Pesenacker A, Ursu S, Wu Q, Lom H, Thirugnanabalan B, et al. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis. J Immunol. 2014;193:2699-708 pubmed 出版商
  80. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed 出版商
  81. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed 出版商
  82. Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson M, Michaelsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014;10:e1004251 pubmed 出版商
  83. Payne T, Blackinton J, Frisbee A, Pickeral J, Sawant S, Vandergrift N, et al. Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition. J Virol. 2014;88:9514-28 pubmed 出版商
  84. Hebel K, Weinert S, Kuropka B, Knolle J, Kosak B, Jorch G, et al. CD4+ T cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program. J Immunol. 2014;192:5160-70 pubmed 出版商
  85. Buggert M, Norstr m M, Salemi M, Hecht F, Karlsson A. Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression. J Immunol. 2014;192:4685-96 pubmed 出版商
  86. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed 出版商
  87. Teirlinck A, McCall M, Roestenberg M, Scholzen A, Woestenenk R, de Mast Q, et al. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. 2011;7:e1002389 pubmed 出版商
  88. Eddings M, Miles A, Eckman J, Kim J, Rich R, Gale B, et al. Improved continuous-flow print head for micro-array deposition. Anal Biochem. 2008;382:55-9 pubmed 出版商
  89. Kooijman R, Coppens A. Insulin-like growth factor-I stimulates IL-10 production in human T cells. J Leukoc Biol. 2004;76:862-7 pubmed